Heidelberg Pharma Market Capitalization vs. Cash Flow From Operations
| HPHA Stock | EUR 2.34 0.04 1.74% |
For Heidelberg Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Heidelberg Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Heidelberg Pharma AG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Heidelberg Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Heidelberg Pharma AG over time as well as its relative position and ranking within its peers.
Heidelberg |
Heidelberg Pharma Cash Flow From Operations vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Heidelberg Pharma's current stock value. Our valuation model uses many indicators to compare Heidelberg Pharma value to that of its competitors to determine the firm's financial worth. Heidelberg Pharma AG is rated # 5 in market capitalization category among its peers. It is rated below average in cash flow from operations category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heidelberg Pharma's earnings, one of the primary drivers of an investment's value.Heidelberg Cash Flow From Operations vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Heidelberg Pharma |
| = | 173.26 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Heidelberg Pharma |
| = | (26.61 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Heidelberg Cash Flow From Operations Comparison
Heidelberg Pharma is currently under evaluation in cash flow from operations category among its peers.
Heidelberg Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Heidelberg Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Heidelberg Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Heidelberg Pharma's important profitability drivers and their relationship over time.
Use Heidelberg Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Heidelberg Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heidelberg Pharma will appreciate offsetting losses from the drop in the long position's value.Heidelberg Pharma Pair Trading
Heidelberg Pharma AG Pair Trading Analysis
The ability to find closely correlated positions to Heidelberg Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Heidelberg Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Heidelberg Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Heidelberg Pharma AG to buy it.
The correlation of Heidelberg Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Heidelberg Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Heidelberg Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Heidelberg Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Heidelberg Pharma position
In addition to having Heidelberg Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Cap ETFs Thematic Idea Now
Large Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large Cap ETFs theme has 714 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Heidelberg Stock
To fully project Heidelberg Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Heidelberg Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Heidelberg Pharma's income statement, its balance sheet, and the statement of cash flows.